For whom?

The programme ‘Leading Innovation in healthcare’ is targeted towards:

  • Executive managers of healthcare providers
  • Medical and clinical leaders
  • Medical and life sciences professionals who hold leading roles in medical affairs, R&D, HEMAR and marketing
  • Healthcare payers
  • Policymakers
  • Health insurance or sickness fund managers
  • Patient organisation leaders

Drive real change in your organisation

A learning experience with real impact on your operations? A management programme tailored to the specific needs of your business? Contact us and discover how we can design and deliver customised programmes for your team that add genuine value to your organisation.

Need help?

Contact our Programme Advisor
Programme Advisor
Tel + 32 9 210 98 84
[email protected]
Find the programme most relevant for you!

Download our programme calendar

Meet Us

Info Sessions & Open Days
02 Feb
Meet our programme advisor online
Category: General Info Sessions

01 Mar
Info Session Executive Education & MBA
Category: General Info Sessions

30 Mar
Experience Vlerick Over Lunch
Category: General Info Sessions

Our approach to learning

It’s all about you and your company’s challenges at Vlerick Business School. Discover our unique approach to learning!

Vlerick expertise in Healthcare Management

  1. European emergency health fund is needed to limit the impact of future crises

    The unprecedented public health crisis caused by COVID-19 overstretched the structures and mechanisms of the European Union, in particular those that deal with emergencies. There is a need for deeper union and collaboration across the European health care sector, as well as a need for a significant financial cushion for rapid and predictably increasing funding. In their new policy paper, Professor David Veredas, Professor Simon Ashby and doctoral researcher Dimitrios Kolokas propose the creation of an Emergency Health Financing Facility (EHFF), which would limit the impact of a future crisis on the EU and its member States.
  2. How to determine the hospital treatment costs for breast cancer patients?

    Healthcare costs are on the rise globally. And factors such as the increase in aging population, advancement in medical technology, and the current reimbursement system contribute to this rise. In addition, we see a lack of cost transparency and understanding centred around costs. A new study by doctoral researcher Erin Roman, Professor Brecht Cardoen and Professor Filip Roodhooft analyses the variability in treatment costs for breast cancer, using several patient and disease related factors, to better understand cost drivers.
All articles